Meta tags:
description=Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.;

Headings (most frequently used words):

in, cancer, md, prostate, for, and, on, the, rectal, bladder, ctdna, data, with, to, psma, aua, nmibc, risk, localized, care, health, discusses, urology, of, why, serves, as, rule, out, neoblast, response, assessment, plus, benefit, key, updates, fda, therapy, pet, radiotherapy, modern, how, should, urologists, coordinate, ivf, symptom, spacer, news, year, patient, selection, times, outcomes, treatment, experts, review, evidence, testosterone, shows, pfs, south, central, section, meeting, mark, tyson, ii, mph, recaps, decipher, may, help, identify, adt, intermediate, 2026, guideline, tibial, uui, sexual, john, sfakianos, integrating, into, trials, brian, mazzarella, reviews, early, water, vapor, spacers, image, guided, broader, adoption, future, research, spacing, jean, nicolas, cornu, phd, vapeur, results, rezūm, bpo, sri, sivalingam, suction, technology, raises, bar, urs, latest, conference, coverage, shorts, from, gsm, guidance, hrt, reform, landmark, women, inguinal, lymph, node, dissection, penile, inside, holep, irina, jaeger, technique, watch, videos, digital, edition, continuing, medical, education, enhancing, role, targeted, strategies, burst, cme, staying, informed, up, date, lupus, nephritis, all, trending, carotuximab, apalutamide, interim, mcrpc, suo, clinical, practice, uroonc, minute, peter, clark, ama, issues, category, cpt, codes, implantable, neuromodulation, aglatimagene, besadenovec, sustained, immune, remodeling, pearls, perspectives, navigating, supplements, pelvic, heather, florio, september, behind, approval, belzutifan, lenvatinib, advanced, ccrcc, robert, motzer, grants, fast, track, designation, pre, biopsy, 68ga, program, enzalutamide, salvage, associated, improved, high, bcr, altaviva, implant, is, reshaping, us, hospitals, expand, cauti, prevention, but, practices, remain, variable, safety, use, comparing, across, technologies, gi, toxicity, reduction, what, mean, patients, trial, design, isolating, its, true, impact, avoiding, false, positives, scans, adjudicating, indeterminate, bone, lesions, imaging, closing, stratification, gaps, ai, armine, smith, addressing, radiotracers, access, barriers,

Text of the page (most frequently used words):
the (47), and (43), #cancer (33), 2026 (27), for (27), prostate (22), more (22), ago (20), with (19), bladder (13), aua (13), read (13), 2025 (13), slide (12), #urology (11), october (11), phd (11), months (10), view (9), discusses (9), health (9), treatment (9), days (9), care (8), hannah (8), clarke (8), plus (8), risk (8), psma (8), data (8), key (8), nmibc (8), news (7), rectal (7), advertisement (7), adt (7), next (7), ctdna (6), how (6), therapy (6), september (6), trial (6), previous (6), patient (6), november (6), lymph (6), why (5), urologists (5), times (5), year (5), benefit (5), pet (5), fda (5), localized (5), from (5), trials (5), sexual (5), mark (5), oct (5), about (4), all (4), rule (4), future (4), radiotherapy (4), phase (4), mri (4), brian (4), mazzarella (4), early (4), vapor (4), reviews (4), role (4), updates (4), john (4), sfakianos (4), clinical (4), 2nd (4), 5th (4), analysis (4), decipher (4), patients (4), help (4), tyson (4), mph (4), recaps (4), results (4), jaeger (4), holep (4), urinary (4), benign (4), december (4), positive (4), nodes (4), highlights (4), asco (4), conference (4), contact (3), board (3), serves (3), out (3), neoblast (3), response (3), assessment (3), should (3), coordinate (3), ivf (3), symptom (3), tibial (3), modern (3), image (3), guided (3), pfs (3), use (3), combination (3), biopsy (3), detection (3), 30th (3), intermediate (3), water (3), robert (3), motzer (3), approval (3), 1st (3), into (3), heather (3), florio (3), supplements (3), perspectives (3), shows (3), codes (3), peter (3), clark (3), including (3), options (3), guideline (3), term (3), may (3), evidence (3), testosterone (3), review (3), cme (3), that (3), bph (3), selection (3), impact (3), writes (3), what (3), clinically (3), facs (3), urologic (3), write (3), access (3), watch (3), oab (3), spacer (3), resources (3), publications (3), your (2), privacy (2), not (2), conditions (2), job (2), editorial (2), broader (2), adoption (2), research (2), spacing (2), uui (2), spacers (2), rtog (2), adding (2), enzalutamide (2), salvage (2), associated (2), 68ga (2), pre (2), landscape (2), belzutifan (2), lenvatinib (2), management (2), ccrcc (2), can (2), integrating (2), pelvic (2), immune (2), remodeling (2), aglatimagene (2), ama (2), neuromodulation (2), stratification (2), emerging (2), bcg (2), unresponsive (2), disease (2), adam (2), weiner (2), uroonc (2), minute (2), suo (2), practice (2), short (2), angela (2), jia (2), identify (2), south (2), central (2), section (2), meeting (2), based (2), earlier (2), 6th (2), abraham (2), morgentaler (2), model (2), experts (2), video (2), enhancing (2), outcomes (2), ideal (2), candidate (2), any (2), bothersome (2), lower (2), tract (2), symptoms (2), due (2), those (2), retention (2), intolerance (2), medication (2), inside (2), irina (2), technique (2), 3rd (2), psmaddition (2), 177lu (2), 617 (2), arpi (2), metastatic (2), study (2), ureteric (2), strictures (2), drug (2), changes (2), cfp (2), are (2), 19th (2), mibc (2), roth (2), when (2), michael (2), oncology (2), awareness (2), practices (2), new (2), deep (2), ilnd (2), indicated (2), frozen (2), pathological (2), superficial (2), nodal (2), packet (2), bahrom (2), ostad (2), stephen (2), culp (2), inguinal (2), node (2), dissection (2), penile (2), armine (2), smith (2), imaging (2), featured (2), women (2), mary (2), dunn (2), msn (2), ocn (2), celeste (2), kirschner (2), cae (2), mhsa (2), expand (2), female (2), shorts (2), sri (2), sivalingam (2), suction (2), technology (2), raises (2), bar (2), urs (2), jean (2), nicolas (2), cornu (2), vapeur (2), rezūm (2), bpo (2), men (2), generation (2), preservation (2), journal (2), peer (2), surgery (2), dysfunction (2), kidney (2), subscribe (2), conferences (2), business (2), sponsored (2), home, rights, reserved, mjh, life, sciences, 259, prospect, plains, bldg, cranbury, 08512, info, choices, sell, information, terms, advertise, altaviva, implant, reshaping, trending, 3506, standard, was, 29th, improved, high, bcr, bipass, evaluating, grants, fast, track, designation, program, findings, ablation, significance, adverse, event, evolving, hif, inhibition, behind, advanced, recap, submissions, regulatory, decisions, optimally, integrated, joins, discuss, potential, amy, pearlman, pearls, navigating, exploratory, analyses, suggest, persistent, after, radiation, besadenovec, sustained, issued, separate, subfascial, subcutaneous, implantation, device, issues, category, cpt, implantable, guidelines, revisions, biomarkers, navigate, this, faq, outlines, recommendations, practical, takeaways, amendment, diagnosis, nrg, 0815, found, predicted, distant, metastasis, identified, greater, sparing, therapies, highlighting, cretostimogene, sequencing, need, comparative, benjamin, saylor, strategic, content, lead, these, protocol, has, been, amended, move, enrollment, course, progression, carotuximab, apalutamide, interim, mcrpc, showing, association, between, explains, saturation, androgen, action, neil, baum, michelle, petri, shivani, garg, burst, staying, informed, date, lupus, nephritis, ana, kiess, erin, grady, ccd, facnm, fsnmmi, himanshu, nagar, scott, tagawa, fasco, facp, targeted, strategies, continuing, medical, education, emphasized, assessed, stage, extends, rpfs, mhspc, endure, plans, enroll, launches, optilume, coated, balloon, 4th, obba, includes, broad, sweeping, will, have, profound, allan, shen, income, estate, tax, provisions, one, big, beautiful, bill, act, exactvu, micro, ultrasound, platform, demonstrated, noninferior, significant, microultrasonography, positioned, alternative, supported, keynote, 905, 303, approves, pembrolizumab, enfortumab, vedotin, cisplatin, ineligible, 21st, once, money, ira, withdrawal, rules, depend, whether, funds, contributions, conversions, earnings, julie, khazan, conversion, makes, sense, doesn, showed, anything, power, combining, scientific, progress, public, engagement, cookson, mmhc, breakthroughs, during, unprecedented, 10th, overall, does, deal, increasing, costs, incurred, staff, rent, supplies, other, overhead, jonathan, rubenstein, painter, final, rvu, adjustments, among, 26th, digital, edition, radiotracers, barriers, addressing, closing, gaps, adjudicating, indeterminate, bone, lesions, avoiding, false, positives, scans, videos, emphasizes, multiple, advancements, aimed, gsm, guidance, hrt, reform, landmark, reassessing, goals, throughout, site, neutral, payment, community, juan, gómez, rivas, febu, actionable, steps, improve, kari, tikkinen, diary, matters, nocturia, workup, policymakers, must, preserve, choice, apps, often, overlooked, complicate, anjali, kapur, cost, effectiveness, favors, beta, agonists, hours, score, guide, design, isolating, its, true, toxicity, reduction, mean, comparing, across, technologies, safety, hospitals, cauti, prevention, but, remain, variable, latest, gopa, iyer, anti, nectin, adc, urothelial, carcinoma, matthew, truesdale, isopsa, performance, without, mpmri, sender, herschorn, bsc, mdcm, frcsc, vibegron, efficacy, older, update, badrinath, konety, mbbs, ravi, munver, first, second, aquablation, systems, jamie, genomics, active, surveillance, kathryn, gessner, challenges, selecting, alan, bryce, advances, nima, almassi, long, themes, shaping, coverage, case, peers, exchange, spotlight, choose, specialty, cosmetic, utuc, controveries, pediatrics, voiding, incontinence, challenging, anatomy, stones, hormone, genomic, testing, genitourinary, cancers, prostatic, hyperplasia, account, evolutions, partners, interactive, tools, live, events, media, begin, journey, tackling, burnout, forums, advisory, previews, listing, podcasts, expert, conversations, law, policy, malpractice, consult, insights, professionals,

Text of the page (random words):
urology times news insights for urologists health professionals business practice management malpractice consult health law policy watch expert conversations shows podcasts news analysis conferences conference listing conference previews conference recaps publications urology times journal editorial advisory board urologists in cancer care supplements and featured publications clinical forums recaps more cme ce resources begin your journey tackling burnout sponsored media live events interactive tools job board partners sponsored resources treatment landscape evolutions subscribe my account business watch conferences publications cme ce resources subscribe benign conditions benign prostatic hyperplasia bladder cancer female urology genitourinary cancers genomic testing hormone therapy kidney cancer kidney stones challenging anatomy men s health next generation imaging oab and incontinence voiding dysfunction pediatrics prostate cancer controveries in urologic cancer drug therapy sexual dysfunction utuc urologic surgery cosmetic surgery choose specialty spotlight peer exchange peers and perspectives case based peer perspectives urology times journal advertisement conference coverage previous slide next slide view more about 2 months ago asco asco 2026 3 key themes shaping the future of gu oncology about 2 months ago aua nima almassi md highlights long term data on bladder preservation in mibc 2 months ago asco alan bryce md highlights key phase 3 advances in prostate cancer 3 months ago aua kathryn gessner md phd on the challenges of selecting patients for bladder preservation 3 months ago aua jamie michael md discusses mri and genomics in active surveillance 3 months ago aua ravi munver md highlights study of first and second generation aquablation systems 3 months ago aua the uroonc minute aua 2026 update on prostate cancer early detection with badrinath r konety mbbs 3 months ago aua sender herschorn bsc mdcm frcsc on vibegron efficacy in older men with oab and bph 3 months ago aua matthew truesdale md on isopsa performance with and without mpmri 3 months ago asco gopa iyer md highlights data on anti nectin 4 adc for metastatic urothelial carcinoma latest news oct 08 2026 news why ctdna serves as a rule out in neoblast s response assessment how should urologists coordinate ivf bladder symptom care oct 08 2026 us hospitals expand cauti prevention but key practices remain variable oct 07 2026 jean nicolas cornu md phd discusses vapeur results for rezūm in bpo oct 07 2026 sri sivalingam md suction technology raises the bar for urs oct 06 2026 previous slide next slide why ctdna serves as a rule out in neoblast s response assessment how should urologists coordinate ivf bladder symptom care broader adoption and future research in rectal spacing safety and patient selection for rectal spacer use comparing 3 year rectal spacer outcomes across technologies rectal spacers in modern image guided radiotherapy jean nicolas cornu md phd discusses vapeur results for rezūm in bpo sri sivalingam md suction technology raises the bar for urs gi toxicity reduction what the data mean for patients rectal spacer trial design isolating its true impact advertisement shorts view all shorts 1 01 decipher score may help guide short term adt use 18 hours ago by angela jia md phd 1 05 cost effectiveness model favors beta 3 agonists for oab 2 days ago by anjali kapur md 1 21 new treatment options complicate bcg unresponsive nmibc care 3 days ago by adam b weiner md 1 more 1 29 why female sexual health is often overlooked in bladder cancer care 3 days ago by armine k smith md 1 07 how apps can expand access to clinical trials 8 days ago by mary dunn msn rn np c ocn 0 28 what policymakers must do to preserve patient choice 9 days ago by celeste kirschner cae mhsa 1 14 why the bladder diary matters in nocturia workup 11 days ago by kari a o tikkinen md phd 0 50 3 actionable steps to improve psma pet access 14 days ago by juan gómez rivas md febu phd 0 23 site neutral payment and the future of community urology 14 days ago by celeste kirschner cae mhsa 0 51 reassessing goals of care throughout cancer treatment 15 days ago by mary dunn msn rn np c ocn previous slide next slide from gsm guidance to hrt reform a landmark year for women s health 2025 featured multiple advancements in women s health aimed at enhancing treatment options and awareness read more inguinal lymph node dissection in penile cancer deep ilnd is indicated for clinically positive lymph nodes and or positive lymph nodes on frozen pathological analysis of the superficial nodal packet write bahrom j ostad md and stephen h culp md phd facs read more inside holep irina jaeger md discusses patient selection and technique jaeger emphasizes that the ideal holep candidate is any patient with bothersome lower urinary tract symptoms due to bph including those with urinary retention or intolerance to medication read more watch view more videos view more previous slide next slide experts review evidence on testosterone and prostate cancer aua south central section meeting mark d tyson ii md mph recaps data in nmibc decipher may help identify adt benefit in intermediate risk prostate cancer avoiding false positives on prostate cancer psma pet scans adjudicating indeterminate bone lesions in prostate cancer imaging closing risk stratification gaps in localized prostate cancer with ai john sfakianos md on integrating ctdna into bladder cancer trials brian mazzarella md reviews early data on water vapor therapy for localized prostate cancer armine k smith md on addressing sexual health in modern bladder cancer care psma pet radiotracers and access barriers in prostate cancer urology times digital edition view more december 26th 2025 inguinal lymph node dissection in penile cancer deep ilnd is indicated for clinically positive lymph nodes and or positive lymph nodes on frozen pathological analysis of the superficial nodal packet write bahrom j ostad md and stephen h culp md phd facs read more december 19th 2025 the 2026 final rule rvu adjustments new codes among key changes the overall 0 impact to urology does not help urology practices deal with increasing costs incurred for staff rent supplies and other overhead write jonathan rubenstein md and mark painter read more december 10th 2025 2025 year in review breakthroughs in urologic oncology during a year of unprecedented awareness if 2025 showed us anything it is the power of combining scientific progress with public engagement writes michael s cookson md mmhc facs read more december 2nd 2025 when a roth conversion makes sense and when it doesn t once money is in a roth ira the withdrawal rules depend on whether the funds are contributions conversions or earnings writes julie khazan cfp read more november 21st 2025 fda approves pembrolizumab plus enfortumab vedotin for cisplatin ineligible mibc the approval is supported by results from the phase 3 keynote 905 ev 303 trial read more november 19th 2025 microultrasonography positioned as alternative to mri for image guided prostate biopsy the exactvu micro ultrasound platform demonstrated noninferior detection of clinically significant prostate cancer vs mri read more november 5th 2025 what income and estate tax provisions are in the one big beautiful bill act the obba includes broad and sweeping changes that will have a profound impact writes allan shen cfp read more november 4th 2025 trial launches of optilume drug coated balloon for benign ureteric strictures the endure 1 study plans to enroll up to 60 patients with benign ureteric strictures read more november 3rd 2025 psmaddition adding 177lu psma 617 to adt plus arpi extends rpfs in mhspc the phase 3 psmaddition trial assessed the combination of 177lu psma 617 plus adt arpi in an earlier stage of metastatic prostate cancer read more november 3rd 2025 inside holep irina jaeger md discusses patient selection and technique jaeger emphasized that the ideal holep candidate is any patient with bothersome lower urinary tract symptoms due to bph including those with urinary retention or intolerance to medication read more previous slide next slide continuing medical education view more video enhancing prostate cancer outcomes the role of psma and targeted treatment strategies ana kiess md phd erin grady md ccd facnm fsnmmi himanshu nagar md ms scott t tagawa md ms fasco facp view more video burst cme staying informed and up to date on the treatment of lupus nephritis michelle petri md mph shivani garg md phd view more previous slide next slide advertisement all news advertisement experts review evidence on testosterone and prostate cancer by abraham morgentaler md neil h baum md october 6th 2026 abraham morgentaler md reviews evidence showing no association between testosterone therapy and prostate cancer risk and explains the saturation model of androgen action carotuximab plus apalutamide shows interim pfs benefit in mcrpc by hannah clarke october 6th 2026 based on these results the trial protocol has been amended to move enrollment earlier in the course of disease progression aua south central section meeting mark d tyson ii md mph recaps data in nmibc by mark d tyson ii m d m p h benjamin p saylor strategic content lead october 5th 2026 mark d tyson ii md mph reviews emerging bladder sparing therapies for nmibc highlighting cretostimogene data treatment sequencing and the need for comparative trials decipher may help identify adt benefit in intermediate risk prostate cancer by angela jia md phd october 5th 2026 an analysis of nrg rtog 0815 found decipher predicted distant metastasis risk and identified patients with greater benefit from short term adt 2026 aua suo nmibc guideline key updates for clinical practice by hannah clarke october 5th 2026 this faq outlines key recommendations and practical takeaways from the aua suo guideline amendment on the diagnosis and treatment of nmibc the uroonc minute key updates to the aua nmibc guideline with peter e clark md by adam b weiner md peter e clark md october 2nd 2026 peter clark md discusses key updates to nmibc guidelines including revisions to risk stratification the emerging role of biomarkers and how to navigate treatment options for bcg unresponsive disease ama issues category i cpt codes for implantable tibial neuromodulation in uui by hannah clarke october 2nd 2026 the ama issued separate codes for subfascial and subcutaneous implantation of a tibial neuromodulation device aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer by hannah clarke october 2nd 2026 exploratory analyses suggest persistent immune remodeling after aglatimagene plus radiation in localized prostate cancer pearls perspectives navigating supplements in pelvic and sexual health with heather florio by amy m pearlman md heather florio october 1st 2026 heather florio joins to discuss the potential role of supplements in pelvic and sexual health john sfakianos md on integrating ctdna into bladder cancer trials by john p sfakianos md october 1st 2026 john p sfakianos md discusses how ctdna can be optimally integrated into bladder cancer clinical trials advertisement fda updates in urology september 2026 by hannah clarke october 1st 2026 a recap of the fda submissions and regulatory decisions in urology from september 2026 behind the fda approval of belzutifan plus lenvatinib in advanced ccrcc with robert motzer md by robert j motzer md hannah clarke september 30th 2026 robert j motzer md discusses the significance of the belzutifan plus lenvatinib approval adverse event management with the combination and the evolving role of hif 2α inhibition in ccrcc brian mazzarella md reviews early data on water vapor therapy for localized prostate cancer by brian mazzarella md september 30th 2026 brian mazzarella md discusses the landscape for intermediate risk prostate cancer and early vapor 2 findings on water vapor ablation fda grants fast track designation to pre biopsy 68ga psma pet program by hannah clarke september 30th 2026 the phase 3 bipass trial is evaluating the use of 68ga psma pet in combination with mri for pre biopsy prostate cancer detection enzalutamide plus salvage radiotherapy associated with improved pfs in high risk bcr by hannah clarke september 29th 2026 in rtog 3506 adding enzalutamide to standard adt and salvage radiotherapy was associated with 2 year pfs benefit view all news advertisement advertisement trending on urology times 1 rectal spacers in modern image guided radiotherapy 2 altaviva tibial implant is reshaping uui therapy 3 how should urologists coordinate ivf bladder symptom care 4 broader adoption and future research in rectal spacing 5 why ctdna serves as a rule out in neoblast s response assessment about us advertise editorial contact us job board terms and conditions privacy do not sell my information your privacy choices contact info 259 prospect plains rd bldg h cranbury nj 08512 2026 mjh life sciences all rights reserved home about us news contact us